Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National …

JC Weinreb, RA Rodby, J Yee, CL Wang, D Fine… - Radiology, 2021 - pubs.rsna.org
Inaugural consensus statements were developed and endorsed by the American College of
Radiology (ACR) and the National Kidney Foundation to improve and standardize the care …

Gadolinium‐based contrast agents: a comprehensive risk assessment

TJ Fraum, DR Ludwig, MR Bashir… - Journal of Magnetic …, 2017 - Wiley Online Library
Gadolinium‐based contrast agents (GBCAs) have been used in magnetic resonance
imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI …

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

H Wei, OT Bruns, MG Kaul, EC Hansen… - Proceedings of the …, 2017 - pnas.org
Medical imaging is routine in the diagnosis and staging of a wide range of medical
conditions. In particular, magnetic resonance imaging (MRI) is critical for visualizing soft …

Metal and metal oxides nanoparticles and nanosystems in anticancer and antiviral theragnostic agents

TI Shabatina, OI Vernaya, NL Shimanovskiy… - Pharmaceutics, 2023 - mdpi.com
The development of antiviral treatment and anticancer theragnostic agents in recent
decades has been associated with nanotechnologies, and primarily with inorganic …

Gadolinium deposition and nephrogenic systemic fibrosis: a radiologist's primer

M Mathur, JR Jones, JC Weinreb - Radiographics, 2020 - pubs.rsna.org
Gadolinium-based contrast agents (GBCAs) have an excellent safety profile. However, over
the last 2 decades, two specific concerns have surfaced. GBCAs are associated with …

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

HS Thomsen, SK Morcos, T Almén, MF Bellin… - European …, 2013 - Springer
Purpose To update the guidelines of the Contrast Media Safety Committee (CMSC) of the
European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and …

Applications for transition-metal chemistry in contrast-enhanced magnetic resonance imaging

A Gupta, P Caravan, WS Price… - Inorganic …, 2020 - ACS Publications
Contrast-enhanced magnetic resonance imaging (MRI) is an indispensable tool for
diagnostic medicine. However, safety concerns related to gadolinium in commercial MRI …

Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis

AH Behzadi, Y Zhao, Z Farooq, MR Prince - Radiology, 2018 - pubs.rsna.org
Purpose To perform a systematic review and meta-analysis to determine if there are
differences in rates of immediate allergic events between classes of gadolinium-based …

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines

AZ Khawaja, DB Cassidy, J Al Shakarchi… - Insights into …, 2015 - Springer
Gadolinium based contrast agents (GBCA) have been linked to the occurrence of
nephrogenic systemic fibrosis (NSF) in renal impaired patients. The exact interaction …

European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic …

R Knobler, P Moinzadeh, N Hunzelmann… - Journal of the …, 2017 - Wiley Online Library
The term 'sclerosing diseases of the skin'comprises specific dermatological entities which
have fibrotic changes of the skin in common. These diseases mostly manifest in different …